Abstract
The most difficult task in antidoping control is the identification of compounds whose origin can be either endogenous or exogenous. This paper presents a procedure for determining the origin of 19-norandrosterone based on the extraction of target components from urine, their multistage purification by semipreparative HPLC, acetylation, and quantification by gas chromatography–isotope-ratio mass spectrometry and gas chromatography–mass spectrometry. Effects of isotope fractionation were not observed in sample preparation. The degree of extraction of the target analytes was 80 ± 5%.
Similar content being viewed by others
References
Galimov, E.M., Sevast’yanov, V.S., Kul’bachevskaya, E.V., and Golyavin, A.A., Mass-Spektrom., 2004, vol. 1, no. 1, p.31.
Mosandl, A., Food Rev. Int., 1995, vol. 11, p.597.
Woodbury, S.E., Evershed, R.P., and Rossel, J.B., J. Chromatogr. A, 1998, vol. 805, p.249.
Dowling, L.M., Boreham, C.J., Hope, J.M., Murray, A.P., and Summons, R.E., Org. Geochem., 1995, vol. 23, p.729.
Hofmann, D., Jung, K., Segschneider, H.-J., Gehre, M., and Schuurmann, G., Isot. Environ. Health Stud., 1995, vol. 31, p.367.
Becchi, M., Aguilera, R., Farizon, Y., Flament, M., Casabianca, H., and James, P., Rapid Commun. Mass Spectrom., 1994, vol. 8, p.304.
WADA Technical Document for Endogenous Anabolic Androgenic Steroids, TD2004EAAS, Montreal: World Anti-Doping Agency, 2004.
WADA Technical Document for the Detection of Synthetic Forms of Endogenous Anabolic Androgenic Steroids by GC–C–IRMS, TD2016IRMS, Montreal: World Anti-Doping Agency, 2016.
Schanzer, W., Clin. Chem., 1996, vol. 42, p. 1001.
Engel, L.L. and Wheeler, M., J. Biol. Chem., 1958, vol. 231, p.159.
Le Bizec, B. and Monteau, F., J. Chromatogr. B: Biomed. Sci. Appl., 1999, vol. 723, p.157.
Saudan, C., Baume, N., and Mangin, P., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2004, vol. 810, p.157.
Trout, G.J., Rogerson, J.H., Cawley, A.T., and Alma, C.W., Aust. J. Chem., 2003, vol. 56, p.175.
Grosse, J. and Anielski, P., Steroids, 2005, vol. 70, p.499.
Mareck-Engelke, U. and Schultze, G., Recent Adv. Doping Anal., 2000, vol. 8, p.145.
Hemmersbach, P., Hagensen, A.H., and Misund, J., Recent Adv. Doping Anal., 2000, vol. 8, p.141.
WADA Technical Document for the Harmonization of Analysis and Reporting of 19-Norsteroids Related to Nandrolone, TD2016NA, Montreal: World Anti-Doping Agency, 2016.
Sobolevsky, T., Krotov, G., Dikunets, M., Nikitina,M., Mochalova, E., and Rodchenkov, G., Drug Test. Anal., 2014, vol. 6, p. 1087.
Piper, T., Buisson, C., and de la Torre, X., GC–C–IRMS Technical Note, Montreal: World Anti-Doping Agency, 2016.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.I. Podolskiy, T.G. Sobolevskii, M.A. Dikunets, 2018, published in Zhurnal Analiticheskoi Khimii, 2018, Vol. 73, No. 3, pp. 224–234.
Rights and permissions
About this article
Cite this article
Podolskiy, I.I., Sobolevskii, T.G. & Dikunets, M.A. Determination of the Origin of 19-Norandrosterone in Urine by Gas Chromatography–Isotope-Ratio Mass Spectrometry for Doping Control. J Anal Chem 73, 283–291 (2018). https://doi.org/10.1134/S1061934818010082
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1061934818010082